Is this the most undervalued Magnificent 7 company?

With a 20% discount to the S&P 500 and faster growth than peers, Alphabet represents a classic mispriced opportunity for pragmatic investors seeking growth at a relative discount.
In the news: Europe bet pays off for Antipodes’ Jacob Mitchell – where he’s investing next

Watch a feature interview with Antipodes CIO Jacob Mitchell on Livewire Markets.
Jacob Mitchell at the 2025 Pinnacle Investment Summit

A replay of Jacob Mitchell’s presentation at the 2025 Pinnacle Investment Summit, held in July 2025.
Antipodes Magnified: Globus Medical Inc (NYSE: GMED)

Antipodes portfolio manager, Nick Cameron, outlines the investment case for US medical device company, Globus Medical.
Antipodes Magnified: Quarterly Update (Q2 2025)

Portfolio Manager, Graham Hay and Investment Director, Alison Savas provide a market and portfolio positioning update for Q2 2025.
Antipodes Magnified: FEMSA (NYSE: FMX)

Emerging Markets Portfolio Manager, John Stavliotis, provides an overview of the investment case for Latin American retailer FEMSA (Fomento Económico Mexicano).
Antipodes Magnified: Thales Group (EPA: HO)

Portfolio Manager, Graham Hay, provides an overview of the investment case for French Aerospace and Defence Company, Thales Group.
CIO Interview: Rethinking Quality Stocks

A new interview with Antipodes CIO, Jacob Mitchell on Livewire Markets
Antipodes Magnified: Quarterly Update (Q1 2025)

Portfolio Manager, Rameez Sadikot and Investment Director, Alison Savas provide a market and portfolio positioning update for Q1 2025.
Antipodes Magnified: Keysight Technologies Inc (NYSE: KEYS)

Portfolio Manager, Graham Hay, provides an overview of the investment case for US electronics manufacturer, Keysight Technologies.